Table 2 Results of the multivariate analysis

From: CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

Variable

Hazard ratio

95% confidence interval

P -value

Baseline CA19-9

   

 Above vs below median

1.84

1.31–2.57

0.0004

CA19-9 Response

   

 <20% drop vs 20% drop

1.95

1.11–3.42

0.019

PS

   

 2–4 vs 0–1

1.75

1.19–2.57

0.004

Sex

   

 Male vs female

1.52

1.06–2.16

0.02